To submit a paper to our journal:

1.              Register as an Author; we encourage you to register also as a reader and a reviewer at the same time.

2.              Follows the Instructions to authors below.

3.              Read our Editorial Policies and our Competing Interest policies

To submit a revised version

1.              Log in

2.              Click on your role as Author

3.              Click on QUEUED FOR REVIEW on the page displayed

4.              Under the heading EDITOR DECISION, upload your revised paper as AUTHOR VERSION using Browse and Upload buttons

5.              Use the NOTIFY EDITOR email to inform editors that the revised version has been submitted

Instructions to Authors

Manuscripts must be written in English. The first page must contain: (a) title, name and surname of the authors; (b) names of the institution(s) where the research was carried out; (c) a running title of no more than 50 letters; (d) acknowledgments; (e) the name and full postal address of the author to whom correspondence regarding the manuscript as well as requests for abstracts should be sent; (f) three to five key words. To accelerate communication, phone, fax number and e-mail address of the corresponding author should also be included. The second page should contain: (a) authors' contributions, i.e., information about the contributions of each person named as having participated in the study (http://www.icmje.org/#author); (b) disclosures about potential conflict of interest.

Dermatology Reports publishes the following types of papers:

Articles: full-length papers describing results of clinical or laboratory studies. Case reports, case series and observations will not be accepted as Articles but are more suitable for a Report (see below). Articles should normally be divided into an abstract, introduction, design and methods, results, discussion and references. The abstract should contain about 250 words and must be structured as follows: background, design and methods, results, conclusions. A maximum of 20 authors is permitted, and additional authors should be listed in an ad hoc appendix.

Reports are shorter communications describing preliminary observations, case-studies and case-series. They should be signed by no more than 10 authors. Brief reports should have an unstructured abstract of no more than 250 words which covers the purpose of the paper, main findings and conclusion. The Report should contain less than 1000 words (excluding references), and a maximum of 3 tables and/or figures (total), and up to 20 references.

Review Articles: no particular format is required for these articles. However, they should have an informative, unstructured abstract of about 250 words. Reviews may also include meta-analyses, guidelines and consensus papers by scientific societies or working groups. These studies must be conducted following proper, widely accepted ad hoc procedures.

Hypotheses and Viewpoints: Present personal, often controversial views on the current topics within the scope of clinical and experimental dermatology. They are often solicited by the editor, but submission are also welcome. The format follows that of the Review paper and the length should be kept below 2000 words.

References should be prepared strictly according to the Vancouver style, which is present in EndNote); for details see the URL: http://www.nlm.nih.gov/bsd/uniform_requirements.html. Where available, URLs for the references should be provided directly within the Word document. References must be numbered consecutively in the order in which they are first cited in the text, and they must be identified in the text by arabic numerals. References to personal communications and unpublished data should be incorporated in the text and not placed under the numbered References.

Peer-review policy

All manuscript submitted to our journals are critically assessed by external and/or inhouse experts in accordance with the principles of Peer Review (http://www.icmje.org/#peer), which is fundamental to the scientific publication process and the dissemination of sound science. Each paper is first assigned by the Editors to an appropriate Associate Editor who has knowledge of the field discussed in the manuscript. The first step of manuscript selection takes place entirely inhouse and has two major objectives: a) to establish the article's appropriateness for our journals' readership; b) to define the manuscript's priority ranking relative to other manuscripts under consideration, since the number of papers that the journal receives is much greater than that it can publish. If a manuscript does not receive a sufficiently high priority score to warrant publication, the editors will proceed to a quick rejection. The remaining articles are reviewed by at least two different external referees (second step or classical peer-review). Manuscripts should be prepared according to the Uniform Requirements established by the International Committee of Medical Journal Editors (ICMJE) (http://www.icmje.org/#prepare). Authorship. All persons designated as authors should qualify for authorship according to the ICMJE criteria (http://www.icmje.org/sponsor.htm) Each author should have participated sufficiently in the work to take public responsibility for the content. Authorship credit should be based only on substantial contributions to (a) conception and design, or analysis and interpretation of data; and to (b) drafting the article or revising it critically for important intellectual content; and on (c) final approval of the version to be published. These three conditions must all be met. Participation solely in the acquisition of funding or the collection of data does not justify authorship. General supervision of the research group is not sufficient for authorship. Any part of an article critical to its main conclusions must be the responsibility of at least one author. Authors should provide a brief description of their individual contributions. Obligation to Register Clinical Trials (http://www.icmje.org/#clin_trials). The ICMJE believes that it is important to foster a comprehensive, publicly available database of clinical trials. The ICMJE defines a clinical trial as any research project that prospectively assigns human subjects to intervention or concurrent comparison or control groups to study the cause-and-effect relationship between a medical intervention and a health outcome. Medical interventions include drugs, surgical procedures, devices, behavioral treatments, process-of-care changes, and the like. Our journals requires, as a condition of consideration for publication, registration in a public trials registry. The journal considers a trial for publication only if it has been registered before the enrollment of the first patient. The journal does not advocate one particular registry, but requires authors to register their trial in a registry that meets several criteria. The registry must be accessible to the public at no charge. It must be open to all prospective registrants and managed by a not-for-profit organization. There must be a mechanism to ensure the validity of the registration data, and the registry should be electronically searchable. An acceptable registry must include a minimum of data elements (http://www.icmje.org/#clin_trials). For instance, ClinicalTrials.gov (www.clinicaltrials.gov), sponsored by the United States National Library of Medicine, meets these requirements. Protection of Human Subjects and Animals in Research. When reporting experiments on human subjects, authors should indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, (as revised in 2008). In particular, PAGEPress adopts the WAME policy on Ethics in Research (http://www.wame.org). Documented review and approval from a formally constituted review board (Institutional Review Board - IRB - or Ethics committee) is required for all studies (prospective or retrospective) involving people, medical records, and human tissues. PAGEPress requires that the authors provide this information on the manuscript's website, and also that they report it explicitly under Design and Methods. When reporting experiments on animals, authors should be asked to indicate whether the institutional and national guide for the care and use of laboratory animals was followed.